Aceclofenac vs Diclofenac for Pain and Inflammation

Primary Recommendation Based on Safety Profile

The American College of Cardiology recommends aceclofenac over diclofenac for patients with mild to moderate pain or inflammation due to its superior gastrointestinal tolerability profile, with significantly lower rates of epigastric discomfort, dyspepsia, and abdominal pain, while providing equivalent or superior pain relief 2

The American Heart Association suggests that diclofenac carries a significantly higher cardiovascular risk compared to other NSAIDs, with a relative risk of 1.63 for vascular events versus placebo, and should be avoided in patients with cardiovascular disease or risk factors 2
The FDA mandates black box warnings for diclofenac regarding cardiovascular thrombotic events, MI, and stroke, highlighting the need for caution when prescribing this medication 2

For standard patients without specific contraindications requiring systemic NSAID therapy, the American College of Rheumatology recommends aceclofenac (100mg twice daily) as the preferred choice 1
For patients with GI risk factors, such as age >65, history of dyspepsia, or concurrent corticosteroid use, aceclofenac's superior GI profile provides meaningful benefit 1

The American Geriatrics Society advises to always use the lowest effective dose for the shortest duration possible to minimize adverse effects, particularly for diclofenac, which has an elevated cardiovascular risk profile that increases with duration of use 1, 2, 5

The American College of Cardiology recommends against combining multiple NSAIDs, as this increases risk without additional benefit 1
The Journal of the American Geriatrics Society suggests attempting acetaminophen (up to 4g daily) before NSAIDs for mild pain, and adding proton pump inhibitor co-therapy for elderly patients or those with GI risk factors requiring NSAIDs 1, 3

The American Heart Association recommends monitoring for cardiovascular effects, such as blood pressure, edema, and signs of heart failure, when prescribing either agent, as both can cause fluid retention 1, 3
The National Kidney Foundation advises monitoring renal function, including baseline and periodic creatinine monitoring, especially in elderly or those with pre-existing renal disease 3